L. Cannella

461 total citations
26 papers, 276 citations indexed

About

L. Cannella is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, L. Cannella has authored 26 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 8 papers in Surgery. Recurrent topics in L. Cannella's work include Sarcoma Diagnosis and Treatment (7 papers), Colorectal and Anal Carcinomas (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). L. Cannella is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Colorectal and Anal Carcinomas (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). L. Cannella collaborates with scholars based in Italy, United States and Malaysia. L. Cannella's co-authors include Carmela Pisano, Sandro Pignata, G. Bruni, Gaetano Facchini, Alfonso De Stefano, Francesco Paolo D’Armiento, Sabino De Placido, Chiara Carlomagno, Salvatore Tafuto and Stefano Pepe and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

L. Cannella

23 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Cannella Italy 9 143 77 70 69 55 26 276
Laura Matteucci Italy 6 141 1.0× 62 0.8× 69 1.0× 38 0.6× 55 1.0× 15 272
Ahmed Kamel Egypt 5 111 0.8× 28 0.4× 90 1.3× 51 0.7× 123 2.2× 15 287
Peter Widschwendter Germany 12 151 1.1× 50 0.6× 72 1.0× 35 0.5× 54 1.0× 31 306
Alessandra Bologna Italy 12 288 2.0× 50 0.6× 118 1.7× 74 1.1× 188 3.4× 37 421
Benjamin Bonhomme France 8 131 0.9× 43 0.6× 45 0.6× 81 1.2× 32 0.6× 15 261
Angeles A. Alvarez United States 8 136 1.0× 108 1.4× 163 2.3× 72 1.0× 188 3.4× 11 405
Susan Percy Ivy United States 6 200 1.4× 47 0.6× 89 1.3× 78 1.1× 10 0.2× 10 414
Luisa Sánchez‐Lorenzo Spain 7 190 1.3× 24 0.3× 92 1.3× 38 0.6× 67 1.2× 23 288
Giuseppa Maltese Italy 11 115 0.8× 84 1.1× 65 0.9× 85 1.2× 215 3.9× 25 394
Cláudia Casanova Italy 9 273 1.9× 62 0.8× 100 1.4× 267 3.9× 58 1.1× 24 421

Countries citing papers authored by L. Cannella

Since Specialization
Citations

This map shows the geographic impact of L. Cannella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Cannella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Cannella more than expected).

Fields of papers citing papers by L. Cannella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Cannella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Cannella. The network helps show where L. Cannella may publish in the future.

Co-authorship network of co-authors of L. Cannella

This figure shows the co-authorship network connecting the top 25 collaborators of L. Cannella. A scholar is included among the top collaborators of L. Cannella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Cannella. L. Cannella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mauro, Annabella Di, Salvatore Tafuto, L. Cannella, et al.. (2025). A Rare Malignant Case of a Primary Pseudomyogenic Haemangioendothelioma of the Bone. Current Oncology. 32(4). 219–219. 1 indexed citations
2.
Bracigliano, Alessandra, et al.. (2025). FAP-α in soft tissue and bone sarcomas: A new potential diagnostic and therapeutic biomarker in the era of precision medicine. Critical Reviews in Oncology/Hematology. 215. 104852–104852.
4.
Bracigliano, Alessandra, Luigi Pio Guerrera, Vincenza Granata, et al.. (2024). The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives. Pharmaceuticals. 17(3). 354–354. 5 indexed citations
5.
Pagliuca, Francesca, A. Chiara, Isabella Giovannoni, et al.. (2024). Synovial Sarcoma of the Kidney: Diagnostic Pitfalls in a Case with Myxoid Monophasic Differentiation and No Epithelial Biomarkers Expression. International Journal of Molecular Sciences. 25(13). 7382–7382.
6.
Arx, Claudia von, Giuseppina Della Vittoria Scarpati, L. Cannella, et al.. (2024). A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial. ESMO Open. 9(5). 103003–103003. 3 indexed citations
8.
Fiorelli, Alfonso, et al.. (2023). One‐way endobronchial valves in the management of complex persistent air leaks in a soft tissue sarcoma patient. Thoracic Cancer. 14(26). 2712–2714. 1 indexed citations
9.
Cannella, L., Rosa Della Monica, Bruno Vincenzi, et al.. (2023). The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine. Cells. 12(12). 1635–1635. 3 indexed citations
10.
Cannella, L., Francesco Perri, Claudia von Arx, et al.. (2022). The Complex Management of the Breast Angiosarcoma: A Retrospective Study. Oncology. 101(4). 234–239. 3 indexed citations
12.
Ottaiano, Alessandro, Alessandra Bracigliano, L. Cannella, et al.. (2021). Is immunotherapy in the future of therapeutic management of sarcomas?. Journal of Translational Medicine. 19(1). 173–173. 23 indexed citations
13.
Carbone, Fabio, Massimiliano Di Marzo, L. Cannella, et al.. (2021). Multidisciplinary Management of Retroperitoneal Sarcoma: Diagnosis, Prognostic Factors and Treatment. Cancers. 13(16). 4016–4016. 15 indexed citations
14.
Minopoli, Michele, Rosa Azzaro, Susan Costantini, et al.. (2020). Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma. Cells. 9(4). 1062–1062. 16 indexed citations
15.
Federico, Piera, et al.. (2017). Long-term survival in a patient with metastatic squamous cell lung carcinoma: A case report. Molecular and Clinical Oncology. 7(5). 928–930. 3 indexed citations
16.
Pignata, Sandro, et al.. (2011). Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up. Annals of Oncology. 22. viii40–viii44. 31 indexed citations
17.
Pignata, Sandro, Frédéric Amant, Giovanni Scambia, et al.. (2011). A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy. Cancer Chemotherapy and Pharmacology. 68(5). 1347–1353. 9 indexed citations
18.
Carlomagno, Chiara, Stefano Pepe, Francesco Paolo D’Armiento, et al.. (2010). Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer. Oncology. 78(5-6). 369–375. 21 indexed citations
19.
Carlomagno, Chiara, A. Farella, L. Bucci, et al.. (2009). Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. Annals of Oncology. 20(5). 906–912. 45 indexed citations
20.
Carlomagno, Cristiano, Francesco Paolo D’Armiento, Anna Crispo, et al.. (2008). Predictive factors of response to neoadjuvant chemoradiotherapy in rectal cancer patirnts.. Annals of Oncology. 19(6). 74–74. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026